摘要:
Electrostimulator (2), comprising an interface for connecting a working electrode (2), as well as a pulse generator that is connected on the output side to the interface for transmitting electrical pulses to the working electrode (10), with a first measuring instrument (10) that is connected to the interface for measuring the electrical voltage present at the interface and/or the electrical current flowing over the interface, as well as an arithmetic unit, connected on the input side to the first measuring instrument, for computing an output signal reflecting the capacity of the working electrode in dependence on the current and/or voltage at the interface.
摘要:
The invention relates to methods of differentiating between ventricular tachycardias (VTs) and supraventricular tachycardias (SVT) with the assistance of morphology detection, and signal processing devices implementing such methods.
摘要:
An electromedical implant having a far-field electrocardiogram detection unit connected or connectable to at least two implantable electrodes, at least one electrode of which is to be placed in the right atrium or right ventricle and is designed to record a far-field electrocardiogram via the terminal for the electrode to be placed in the right atrium or the right ventricle and one other electrode. The far-field electrocardiogram detection unit is connected to a far-field electrocardiogram evaluation unit, which is configured to detect signal features of the far-field electrocardiogram associated with an excitation or contraction of the left atrium and/or the left ventricle of the heart in a far-field electrocardiogram recorded by the far-field electrocardiogram detection unit.
摘要:
The present invention relates to new compounds of general formula having thrombin-inhibiting activity. Exemplary are: 1-Methyl-2-[4-(N-hydroxyamidino)-phenylaminomethyl]-benzimidazol-5-yl-carboxylic acid-(N-2-pyridyl-N-2-ethoxycarbonylethyl)-amide, and 1-Methyl-2-[4-(N-methoxycarbonylamidino)-phenylaminomethyl]-benzimidazol-5-yl-carboxylic acid-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amide.
摘要:
An implantable medical device incorporates a central control unit (14) for controlling the internal and external functions of the device, a memory unit comprising program memory, main and/or data memory (20, 21, 22) for the central control unit (14), having at least one non-volatile read-write memory unit that is based on an optical storage medium and holds the stored information energy-free, and an off-the-line power supply (18) for the implantable device.
摘要:
The invention relates to methods of differentiating between ventricular tachycardias (VTs) and supraventricular tachycardias (SVT) with the assistance of morphology detection, and signal processing devices implementing such methods.
摘要:
An implantable heart stimulator (10), which has a right-atrial sensing unit (62), which is connected or is to be connected to a right-atrial electrode for recording electrical potentials of the myocardium of a right atrium, and is implemented to process electrical signals recorded via the right-atrial electrode, and to detect signal features characterizing a right-atrial stimulation and contraction in the electrical signal recorded via the right-atrial electrode. The heart stimulator (10) additionally has a left-ventricular sensing unit (66), which is connected or is to be connected to a left-ventricular electrode for recording electrical potentials of the myocardium of a left ventricle of a heart and is implemented to process electrical signals recorded via the left-ventricular electrode. The left-ventricular sensing unit (66) is implemented to detect signal features in the electrical signal recorded via the left-ventricular electrode which characterize a left-atrial contraction.
摘要:
An electromedical implant having a far-field electrocardiogram detection unit connected or connectable to at least two implantable electrodes, at least one electrode of which is to be placed in the right atrium or right ventricle and is designed to record a far-field electrocardiogram via the terminal for the electrode to be placed in the right atrium or the right ventricle and one other electrode. The far-field electrocardiogram detection unit is connected to a far-field electrocardiogram evaluation unit, which is configured to detect signal features of the far-field electrocardiogram associated with an excitation or contraction of the left atrium and/or the left ventricle of the heart in a far-field electrocardiogram recorded by the far-field electrocardiogram detection unit.
摘要:
An implantable heart stimulator (10), which has a right-atrial sensing unit (62), which is connected or is to be connected to a right-atrial electrode for recording electrical potentials of the myocardium of a right atrium, and is implemented to process electrical signals recorded via the right-atrial electrode, and to detect signal features characterizing a right-atrial stimulation and contraction in the electrical signal recorded via the right-atrial electrode. The heart stimulator (10) additionally has a left-ventricular sensing unit (66), which is connected or is to be connected to a left-ventricular electrode for recording electrical potentials of the myocardium of a left ventricle of a heart and is implemented to process electrical signals recorded via the left-ventricular electrode. The left-ventricular sensing unit (66) is implemented to detect signal features in the electrical signal recorded via the left-ventricular electrode which characterize a left-atrial contraction.
摘要:
The present invention relates to new compounds of general formula having thrombin-inhibiting activity. Exemplary are: 1-Methyl-2-[4-(N-hydroxyamidino)-phenylaminomethyl]-benzimidazol-5-yl-carboxylic acid-(N-2-pyridyl-N-2-ethoxycarbonylethyl)-amide, and 1-Methyl-2-[4-(N-methoxycarbonylamidino)-phenylaminomethyl]-benzimidazol-5-yl-carboxylic acid-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amide.